The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized control trial to validate mitigation of chemotherapy-induced peripheral neuropathy by limb-cooling apparatus in breast cancer patients receiving paclitaxel (CECILIA).
 
Toshimi Takano
Honoraria - Daiichi Sankyo; Lilly
 
Chikako Funasaka
Honoraria - Daiichi Sankyo/Astra Zeneca (Inst); Eisai; Lilly; MSD
Other Relationship - Daiichi Sankyo/Astra Zeneca
 
Nobuaki Matsubara
Honoraria - Sanofi
Consulting or Advisory Role - Amgen; AstraZeneca; Janssen; Lilly; Pfizer; Sanofi; Seagen
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bayer Yakuhin (Inst); Chugai Pharma (Inst); Eisai (Inst); Janssen (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Roche/Genentech (Inst); Seagen (Inst); Takeda (Inst)
 
Yoichi Naito
Consulting or Advisory Role - AstraZeneca; Bayer; Chugai Pharma; Daiichi Sankyo; Gilead Sciences; Gilead Sciences; Lilly; Pfizer; Taiho Pharmaceutical; Takeda
Speakers' Bureau - AstraZeneca; Bayer Yakuhin; Bristol-Myers Squibb Japan; Chugai Pharma; Eisai; FUJIFILM Toyama Chemistry; Gilead Sciences; Guardant Health; Hisamitsu Pharmaceutical; Lilly; MSD; Mundipharma; Novartis; Ono Yakuhin; Pfizer; Shionogi; Taiho Pharmaceutical; Takeda
Research Funding - Abbvie; AstraZeneca Japan; Boehringer Ingelheim; Chugai/Roche; Daiichi Sankyo; Eisai; Gilead Sciences; Lilly; Pfizer; Taiho Pharmaceutical; Takeda
 
Meiko Nishimura
No Relationships to Disclose
 
Masashi Wakabayashi
Honoraria - Nihon Medi-Physics
 
Chihiro Kondoh
Honoraria - Astellas Pharma; Bristol-Myers Squibb Company; Chugai Pharma; Daiichisankyo Company; Eisai; Janssen; Kyowa Kirin International; Merck KGaA; MSD K.K.; Ono Pharmaceutical; Sanofi; Takeda
Consulting or Advisory Role - Astellas Pharma
Research Funding - Astellas Pharma (Inst); DAIICHI SANKYO COMPANY, LIMITED (Inst); MSD K.K (Inst)
 
Yukinori Ozaki
Honoraria - Chugai Pharma; Daiichi Sankyo; Kyowa Kirin International; Lilly; Pfizer
 
Ako Hosono
No Relationships to Disclose
 
Takayuki Kobayashi
No Relationships to Disclose
 
Hiromichi Nakajima
Employment - Otsuka (I)
Honoraria - AstraZeneca; Chugai Pharma; Lilly Japan; Ono Pharmaceutical; Pfizer; Sanofi/Regeneron; Taiho Pharmaceutical; Takeda
 
Nozomu Fuse
Honoraria - Astellas Pharma; AstraZeneca
 
Akihiro Sato
Honoraria - Astellas Pharma; AstraZeneca; Dainippon Sumitomo Pharma
Research Funding - Aspyerian Therapeutics (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Chugai Pharma (Inst); Daiichi Sankyo/UCB Japan (Inst); Dainippon Sumitomo Pharma (Inst); Eisai (Inst); MSD (Inst); Oncolys BioPharma (Inst); Ono Pharmaceutical (Inst); Pentax Medical Devices (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Keita Mori
Honoraria - Chugai Pharma; Lilly Japan; Ono Pharmaceutical
Consulting or Advisory Role - Welby
 
Akiko Hanai
Honoraria - Daiichi Sankyo/UCB Japan
Consulting or Advisory Role - Asahi Kasei
 
Michihiko Nishina
Employment - Nippon Sigmax Co., Ltd.
 
Takuya Kigawa
Employment - Nippon Sigmax Co., Ltd.
 
Sadamoto Zenda
Honoraria - Bristol-Myers Squibb Japan; Maruho; Merck; Ono Yakuhin
 
Toru Mukohara
Honoraria - AstraZeneca; Chugai Pharma; Eisai; Kyowa Kirin; Lilly Japan; Novartis; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - Eisai; Micin
Research Funding - AstraZeneca (Inst); Chugai Pharma (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Eisai (Inst); Gilead Sciences (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Sanofi (Inst); Sysmex (Inst)